Screener
Penumbra PEN R&D
R&D at other companies
Other financials
Where this comes from
Reported directly by Penumbra in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The source filing: Penumbra’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001321732-26-000019
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cost of revenue | 121,347 | 108,257 |
| Gross profit | 253,411 | 215,883 |
| Operating expenses: | ||
| Research and development | 22,382 | 22,077 |
| Sales, general and administrative | 192,795 | 153,456 |
| Total operating expenses | 215,177 | 175,533 |
| Income from operations | 38,234 | 40,350 |
| Interest and other income, net | 3,454 | 3,508 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Penumbra's R&D?
- Penumbra (PEN) reported R&D of $22.38M in Q1 2026.
- How has Penumbra's R&D changed year-over-year?
- Penumbra's R&D increased by 1.4% year-over-year, from $22.08M to $22.38M.
- What is the long-term trend for Penumbra's R&D?
- Over 4 years (2021 to 2025), Penumbra's R&D has grown at a -3.7% compound annual growth rate (CAGR), from $104.55M to $89.77M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Penumbra's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude